Biden Crime Family to reap massive profits from monkeypox vaccines
Profits will skyrocket even more if Biden’s FDA grants full approval for the shots
As you might expect, the current White House occupant is about to rake in boatloads of cash from the new monkeypox “vaccines” that are currently under development.
The Penn Biden Center, a globalist think tank at the University of Pennsylvania Hospital, is receiving a flood of cash, we now know, to create the next wave of plandemic injections at warp speed. And as its name suggests, the Penn Biden Center is directly tied to the Biden Crime Family.
Patrick Howley told Owen Shroyer during a recent live transmission of “War Room” that the pharmaceutical-industrial complex is greasing the skids for the Biden Crime Family to profit heavily from the monkeypox false flag event that is now unfolding.
“The University of Pennsylvania, which hosts Joe Biden’s think tank the Penn Biden Center and paid Joe Biden in the lead-up to his run for president, got paid by the company Bavarian Nordic to perform a clinical trial on the Bavarian Nordic monkeypox vaccine,” stated an article by Howley that was published by National File.
“Joe Biden’s host university profited from helping Bavarian Nordic develop the MVA-BN monkeypox vaccine.”
The Penn Biden Center, by the way, is financed by UPenn’s general funds. The MVA-BN jab being tested there is known in the United States as the Jynneos monkeypox vaccine.
A 2014 document further revealed that UPenn is being paid directly by Bavarian Nordic, which received $100 million in U.S. taxpayer funding from none other than career government employee Tony Fauci.
